Identifying Factors Affecting the Pharmaceutical Supply Chain Management in Iran
AbstractBackground: This study has been conducted with the aim to identify factors affecting the management of pharmaceutical supply chain in Iran. Materials and Methods: This study was of a combined(quantity–quality)type. The assessment tool was a Likert scale-based five-option questionnaire. Content validity assessment was obtained at 0.89 according to the CVR, and construct validity was at 0.971 using factor analysis.KMO statistics was very high and indicative of a correlation of scale items.In terms of reliability of assessment in researcher-made tools, the selected items were analysed, and the results obtained showed that the applied scales enjoyed significant reliability.The sample for the survey was100experts in the pharmaceutical system of the country’s Food and Drug Administration, pharmaceutical companies, technical officer of pharmacies and the ministry of health and medical education. They were selected by purposive stratified non-random sampling and snowball methods. The data was analysed by exploratory factor analysis using SPSS and LISREL. Results: The results of the current study indicated a pattern with significant and direct relationship between independent and dependent variables of medicine supply chain management. The most important indicators of medicine supply chain management in order of priority were distribution management with impact factor, IT management, pharmaceutical structure, pharmaceutical structure programming, coordination, enterprise resource planning, logistics management, knowledge management, financial management, globalization, customer relationship management, and medical insurance system. Conclusions: According to the patterning indexes, it can be mentioned that the representative model has had a good fit, and a desirable compliance between a structural model with experimental data and expert opinion has been provided.[GMJ.2017;6(4):346-55] DOI: 10.22086/gmj.v6i4.869
Jahanbani E, Shakoori R, Bagheri-Kahkesh M. Drug Supply Chain Management and Implementation of Health Reform Plan in Teaching Hospital Pharmacies of Ahvaz, Iran. HPR. 2016;1(4):141-5.
Yousefi N, Alibabaei A. Information flow in the pharmaceutical supply chain. Iranian journal of pharmaceutical research: IJPR. 2015;14(4):1299.
Mahallati V. Management of Drug Supply Chain at 2025. In Persian. 2012.
Bose NK. Pharmaceutical Good Distribution Practices – A Review of Global Scenario. IJPSR. 2015;6(12):1449-52.
Jaberidoost M, Nikfar S, Abdollahiasl A, Dinarvand R.
Pharmaceutical supply chain risks: a systematic review. DARU. 2013;21(1):69.
Brown MT, Bussell JK, editors. Medication adherence: WHO cares? Mayo Clin Proc; 2011: Elsevier.
Shieshia M, Noel M, Andersson S, Felling B, Alva S, Agarwal S, et al. Strengthening community health supply chain performance through an integrated approach: Using mHealth technology and multilevel teams in Malawi. J Glob Health. 2014;4(2).
Schouten EJ, Jahn A, Ben-Smith A, Makombe SD, Harries AD, Aboagye-Nyame F, et al. Antiretroviral drug supply challenges in the era of scaling up ART in Malawi. J Int AIDS Soc 2011;14(Suppl 1):S4.
Ventola CL. The drug shortage crisis in the United States: causes, impact, and management strategies. Parmacy and Therapeutics. 2011;36(11):740.
Kalantari M, Pishvayi MS. A Robust Possibilistic Programming Approach to Drug Supply Chain Master Planning. IJIMSE. [In Persian]. 2016;4(7):49-67.
Bedouch P, Baudrant M, Detavernier M, Rey C, Brudieu E, Foroni L, et al., editors. Drug supply chain safety in hospitals: current data and experience of the Grenoble university hospital. Annales Pharmaceutiques Francaises; 2009.
Olfat L, Amiri M, Ebrahimpour Azbari M. A Network data envelopment analysis model for supply chain performance evaluation: real case of Iranian pharmaceutical industry. IJIE. 2014;25(2):125-38.
Susarla N, Karimi IA. Integrated supply chain planning for multinational pharmaceutical enterprises. Computers & Chemical Engineering. 2012;42:168-77.
Holm MR, Rudis MI, Wilson JW. Medication supply chain management through implementation of a hospital pharmacy computerized inventory program in Haiti. Global Health Innovation Act. 2015;8.
Blackstone EA, Fuhr Jr JP, Pociask S. The health and economic effects of counterfeit drugs. Am Health Drug Benefits. 2014;7(4).
Ehrhardt M, Hutchens R, Higgins S. HEALTHCARE-Five Steps toward a Revitalized Pharmaceutical Supply Chain-Global drug companies are facing disruption. One powerful strategic response is to rethink their manufacturing and operations footprints. Strategy and Business. 2012(66):26.
Stevens GC. Integrating the supply chain. International Journal of Physical Distribution & Materials Management. 1989;19(8):3-8.
Sweeney E. Supply chain management and the value chain: arrow.dit.ie; 2009.
Christopher M. Logistics & supply chain management: Pearson UK; 2016.
Bowersox DJ, Closs DJ, Cooper MB. Supply chain logistics management: McGraw-Hill New York, NY; 2002.
Stank TP, Keller SB, Daugherty PJ. Supply chain collaboration and logistical service performance. Journal of Business Logistics. 2001;22(1):29-48.
Lee HL. Aligning supply chain strategies with product uncertainties. California Management Review 2002;44(3):105-19.
Morash EA, Lynch DF. Public policy and global supply chain capabilities and performance: a resource-based view. Journal of Immunological Methods. 2002;10(1):25-51.
Rosenzweig ED, Roth AV, Dean JW. The influence of an integration strategy on competitive capabilities and business performance: an exploratory study of consumer products manufacturers. The Journal of The Minerals, Metals & Materials Society. 2003;21(4):437-56.
Lotfi Z, Mukhtar M, Sahran S, Zadeh AT. Information sharing in supply chain management. Procedia Technology. Procedia Technology. 2013;11:298-304.
Li Y, Meinel C, editors. A model-based software development process for Supply Chain Monitoring applications. RFID-Technology and Applications (RFID-TA), 2010 IEEE International Conference on; 2010: IEEE.
Mehralian G, Rajabzadeh Gatari A, Morakabati M, Vatanpour H. Developing a suitable model for supplier selection based on supply chain risks: an empirical study from Iranian pharmaceutical companies. IJPR. 2012;11(1):209-19.
Rajabzadeh A, Mehralian G, Zarenezhadb F, Rasekh HR. Developing a model for agile supply: An empirical study from Iranian pharmaceutical supply chain. IJPR. 2013;12:193-205.
Delgoshaei B, Tourani S, Khalesi N, Dindoust P. Pricing and reimbursement of pharmaceuticals in Iran and selected countries: a comparative study. JHAE. 2006;8(22):55-66.
Pedroso MC, Nakano D. Knowledge and information flows in supply chains: A study on pharmaceutical companies. IJPE. 2009;122(1):376-84.
Mekawie S, Elragal A. ERP and SCM Integration: The Impact on Measuring Business Performance. IJEIS. 2013;9(2):106-24.
Ince H, Imamoglu SZ, Keskin H, Akgun A, Efe MN. The impact of ERP systems and supply chain management practices on firm performance: case of Turkish companies. Procedia - Social and Behavioral Sciences. 2013;99:1124-33.
el Shoghari R, Abdallah K. The Impact of Supply Chain Management on Customer Service (A Case Study of Lebanon). Management. 2016;6(2):46-54.
Hong P, Dobrzykowski D, Won Park Y, Näslund D, Hulthen H. Supply chain management integration: a critical analysis. Benchmarking: An International Journal. 2012;19(4/5):481-501.
Fanjiang G, Grossman JH, Compton WD, Reid PP. Building a better delivery system: a new engineering/health care partnership: National Academies Press; 2005.
Tseng M-L, Wu K-J, Nguyen TT. Information technology in supply chain management: a case study. rocedia - Social and Behavioral Sciences. 2011;25:257-72.
Wuttke DA, Blome C, Henke M. Focusing the financial flow of supply chains: An empirical investigation of financial supply chain management. IJPE. 2013;145(2):773-89.
Outahar I, Nfaoui E, El Beqqali O, editors. Implementing knowledge management in supply chain: Literature review. Computer Systems and Applications (AICCSA), 2013 ACS International Conference on; 2013: IEEE.
Buckley GJ, Gostin LO. Countering the problem of falsified and substandard drugs: National Academies Press; 2013.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).